📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-14 17:56
0 analysed today
FollowTelegram
0
Today
152,077
All-time analysed
43,619
Positive
6,746
Negative
92,865
Neutral
8,779
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
2 announcements match the current filters (relevance ≥ 5).
Indian Phosphate Reports Q2 FY27 Consolidated Revenue Up 83.8% YoY to ₹450.2 Cr
Indian Phosphate Limited released its Q2 FY27 business update, highlighting an 83.78% YoY surge in consolidated revenue to ₹45,020.71 Lakhs (₹450.21 Cr) compared to ₹24,496.84 Lakhs in Q2 FY26. For H1 FY27, consolidated revenue increased 82.38% YoY to ₹91,030.66 Lakhs (₹910.31 Cr), representing approximately 46.4% of its TTM revenue (₹1,963 Cr). Growth was driven by the commercial ramp-up of the Cuddalore unit, including a 100 MT/day Anionic Surfactant plant commissioned in June 2026, alongside entry into potassic fertilizers under an arrangement with K+S Middle East.
Confidence: HIGH
What changedIndian Phosphate released its Q2 FY27 business update showing an 83.8% jump in quarterly consolidated top-line following new capacity commercialization at Cuddalore.
Why it mattersThe ramp-up of the 100 MT/day anionic surfactant unit and new SOP fertilizer distribution validate the company's geographical and product diversification beyond its traditional SSP fertilizer base.
Q2 FY27 Consolidated Revenue: ₹45,020.71 LakhsQ2 FY27 Standalone Revenue Growth: 94.39%H1 FY27 Consolidated Revenue: ₹91,030.66 LakhsAnionic Surfactant Capacity: 100 MT/dayH1 FY27 Revenue vs TTM Revenue: ~46.4%
📅 Short termMarket sentiment should react positively to strong operational top-line momentum, though investors will await detailed profit margins in the audited/reviewed quarterly filing.
📈 Long termDiversifying into chemical surfactants and high-value potassic fertilizers helps insulate the company from government-regulated SSP subsidy regimes and expands its presence in South India.
⚠ Risk flags
- Profitability figures not disclosed in the update; top-line surge might face raw material cost inflation (LABSA inputs)
- Sri Lanka Eppawala rock phosphate value-addition project is still under government evaluation
Key Highlights
Q2 FY27 consolidated revenue surged 83.78% YoY to ₹45,020.71 Lakhs from ₹24,496.84 Lakhs
H1 FY27 consolidated revenue reached ₹91,030.66 Lakhs, growing 82.38% YoY
Commercial production of the Anionic Surfactant plant at Cuddalore commenced in June 2026 with a 100 MT/day capacity
Brickwork Ratings assigned a credit rating of BWR A-/Stable (fund based) and BWR A2+ (non-fund based) in June 2026
👀 What to Watch
Track the upcoming full Q2 FY27 financial results for margin performance, as well as regulatory updates on the Sri Lanka rock phosphate concession proposal.
81% YoY Consolidated Revenue Growth in Q1 FY27 for Indian Phosphate Limited
Indian Phosphate Limited (IPHL) reported a robust Q1 FY27 business update with consolidated revenue reaching ‑254.17 Cr, an 81% increase year-on-year. Standalone revenue grew even faster at 87% YoY to ‑232.08 Cr, while both segments saw a 43% sequential (QoQ) growth. The performance was driven by strong demand across its chemicals and fertilizer segments, supported by integrated manufacturing in Rajasthan and Tamil Nadu. This quarterly revenue represents approximately 13% of the TTM revenue of ‑1963 Cr, indicating a strong start to the fiscal year.
Confidence: HIGH
What changedIPHL has reported a significant acceleration in revenue growth, nearly doubling its standalone top-line compared to the same quarter last year.
Why it mattersThe growth suggests successful utilization of expanded LABSA capacity and the new Cuddalore plant, validating the company's geographic expansion strategy into South India.
Consolidated Revenue (Q1 FY27): ‑254.17 CrYoY Revenue Growth: 81%QoQ Revenue Growth: 43%Standalone Revenue (Q1 FY27): ‑232.08 CrQ1 Revenue vs TTM Revenue: ~13%
📅 Short termThe stock is likely to react positively to the high double-digit growth figures in the short term as it signals strong operational momentum.
📈 Long termLong-term value depends on the company's ability to maintain this growth while improving margins through backward integration and specialty chemical expansions like Magnesium Sulphate.
⚠ Risk flags
- Volatility in raw material prices for LABSA
- Dependence on government subsidy regimes for the SSP fertilizer segment
Key Highlights
Consolidated revenue increased 81% YoY to ‑254.17 Cr for the quarter ended June 30, 2026
Standalone revenue grew 87% YoY to ‑232.08 Cr, reflecting strong core operations
Sequential growth (QoQ) for both standalone and consolidated revenue stood at 43%
Distribution network expanded to cover 14+ states across India
Company is pursuing backward integration through captive Sulphuric Acid manufacturing and rock phosphate mining
👀 What to Watch
Investors should monitor the full Q1 FY27 financial results to see if this high revenue growth translates into margin expansion, given the company's historically thin OPM of 3.2%.
